Opinion

Video

Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease

Expert panelists discuss the implementation of a treat-to-target approach for the long-term management of inflammatory bowel disease (IBD), drawing upon data from the STARDUST and REACT-2 trials to support their recommendations and insights into optimizing patient outcomes through this strategy.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
4 experts are featured in this series.
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
© 2025 MJH Life Sciences

All rights reserved.